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Bradykinin  (BK) and  des-Arg9-bradykinin  (DBK)  of  kallikrein-kinin  system  exert  its effects  mediated  by
the  B2 (B2R)  and  B1 (B1R)  receptors,  respectively.  It was  already  shown  that  the  deletion  of  kinin  B1R
or  of  B2R induces  upregulation  of the  remaining  receptor  subtype  [10,12,16,28,36].  However  studies  on
overexpression  of B1R  or B2R in  transgenic  animals  have  supported  the importance  of the  overexpressed
receptor  but  the  expression  of  another  receptor  subtype  has not  been  determined  [17,19,33].  Previous
study  described  a marked  vasodilatation  and  increased  susceptibility  to endotoxic  shock  which  was asso-
ciated  with  increased  mortality  in  response  to DBK  in  thoracic  aorta  from  transgenic  rat overexpressing
the  kinin  B1R  (TGR(Tie2B1))  exclusively  in the  endothelium.  In another  study,  mice  overexpressing  B1R  in
multiple  tissues  were  shown  to  present  high  susceptibility  to  inﬂammation  and  to  lipopolysaccharide-
induced  endotoxic  shock.  Therefore  the  role  of B2R was  investigated  in the  thoracic  aorta  isolated  frominin receptors
CE
TGR(Tie2B1) rats  overexpressing  the  B1R  exclusively  in the  vascular  endothelium.  Our ﬁndings  provided
evidence  for  highly  increased  expression  level  of  the B2R in the  transgenic  rats. It was  reported  that  under
endotoxic  shock,  these  rats  exhibited  exaggerated  hypotension,  bradycardia  and  mortality.  It can  be  sug-
gested  that  the  high  mortality  during  the  pathogenesis  of  endotoxic  shock  provoked  in the  transgenic
TGR(Tie2B1) rats  could  be  due  to  the  enhanced  expression  of B2R  associated  with  the  overexpression  of
the  B1R.. Introduction
Kinins are potent inﬂammatory mediators and induce contrac-
ion and relaxation in several vascular and non-vascular smooth
uscles [4,24]. The kinins belong to the kallikrein-kinin system
KKS) involved in the renal and cardiovascular regulation [4,13].
radykinin (BK: Arg1-Pro2-Pro3-Gly4-Phe5-Ser6-Pro7-Phe8-Arg9),
s a nonapeptide hormone which mediates the action of the con-
titutively expressed kinin B2 receptor (B2R). On the other hand,
he kinin B1 receptor (B1R) is an induced receptor and its effect is
ediated by des-Arg9-BK (DBK), a 1–8 fragment of BK [25]. The
xpression level of B1R is very low in healthy tissues but high
n inﬂammatory conditions or after time-dependent incubation
13,15,25].Genetically engineered animals have been inbred to allow a bet-
er understanding of the function of kinins and the role of each
ubtype of receptors. Therefore several transgenic animals have
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been created, such as mice deﬁcient in the kinin B1R [21,28], in
the kinin B2R [5,9,10,12] and also in both kinin B1R and B2R [8], as
well as mice overexpressing the B1R [17,19] or the B2R [34]. It has
been shown that the lack of kinin receptors may  affect the reactiv-
ity of the vascular smooth muscle preparations or cause changes
in the expression level of some receptors of kallikrein kinin system
(KKS) and renin angiotensin system (RAS) in the same tissue [26].
A cross-talk between the RAS and KKS is based on the effect
of angiotensin I (AngI) converting enzyme (ACE), which is respon-
sible for the cleavage of AngI into the potent vasoconstrictor
angiotensin  II (AngII) and of the vasodilator BK into non-active pep-
tide fragments [4,6,37]. The ACE enzyme is mostly expressed in
the endothelial vascular smooth muscle, mainly in the pulmonary
arteries [4].
Several  studies have demonstrated interactions between kinin
receptors and AngII type 1 receptor (AT1R). Therefore it was
reported that spontaneous interaction of B1R and B2R increases the
Open access under the Elsevier OA license.ability of B1R but not of B2R to be stimulated by its agonist [11]; het-
erodimerization between B2R and AT1R causes increased activation
of G protein signaling triggered by AT1R but not by B2R [1]; AngII
may regulate the expression of B2R mRNA [32], that B2R gene is a
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ownstream target of AngII AT1R [29]; the activity of angiotensin
onverting enzyme (ACE) is enhanced in kinin B1R knockout mice
B1KO) [20] and by an interaction between ACE and kinin B2R [27].
These data from the literature about cross-talk between RAS
nd KKS and the evidence for expression of AngII AT1R protein
nd mRNA in endothelial cells [18,22,23,31,35] provide rationale
or studying the interactions between AngII and BK receptors in
ddition to the assessment about vascular reactivity of the kinin
s well as the expression level of B2R in the aorta isolated from
ransgenic (TGR(Tie2B1)) rats.
. Material and methods
.1.  Animals
Experiments were carried out using 300–350 g Sprague-Dawley
ats as control (WT) and overexpressing B1R (TGR(Tie2B1)), [17]
rom the “Centro de Desenvolvimento de Modelos Experimentais”
CEDEME) of the Universidade Federal de São Paulo (UNIFESP). The
nimals were maintained on standard rat chow at 21–23 ◦C and
ept on 12 h light: 12 h dark cycle and allowed ad libitum access
o food and water. The protocols used in this study were in accor-
ance with current guidelines for the care of laboratory animals
nd ethical guidelines for investigations approved by the Animal
are Committee of UNIFESP.
.2.  Isometric relaxation and contraction recordings
Thoracic aorta were isolated from rat, cleared of connective
issue and mounted as ring preparations into 5 ml  organ baths.
he rings of aorta were bathed in carboxygenated (95% O2/5%
O2), and modiﬁed Krebs-Ringer solution: 144 mM NaCl, 5 mM
Cl, 1.1 mM MgSO4, 25 mM NaHCO3, 1.1 mM NaH2PO4, 1.25 mM
aCl and 5.5 mM glucose at 37 ◦C (pH 7.4). Resting tension was
aintained at 0.5 g and the tissues were left to equilibrate for
0 min, with frequent changing of bathing solution. The tissue via-
ility was assessed with a priming dose of 80 mM KCl and 1 M
orepinephrine (NE), as described previously by [30]. Following a
0 min  washout and recovery period, changes in tension produced
y the stimulants were measured with an isometric transducer
RI201 (Panlab s.l., Cornella, Barcelona, Spain) through an ampli-
er Powerlab 4/30 and software Labchart Pro V7 (ADInstruments,
olorado Springs, CO, USA).
Cumulative  concentration–response curves were con-
tructed for BK applying increasing concentrations (0.1 nM
o 1 M)  of the agonist. On the other hand non-cumulative
oncentration–response curves were obtained for AngI and Ang
I to avoid desensitization, as described previously by [3]. The
resence of the endothelium in the thoracic aorta was conﬁrmed
harmacologically by the acetylcholine-induced relaxing effect
n aortic rings pre-contracted with NE 1 M.  Some curves were
btained in the presence and absence of lisinopril (1 M),  an ACE
nhibitor, pre-incubated for 20 min  and in the presence of R-715,
peciﬁc antagonist of B1R, since the tissue was isolated from the
nimal. The effect of speciﬁc blockers of B2R, HOE-140 (1 M),  the
itric oxide synthase inhibitor, L-NAME (1 mM)  and the cyclooxy-
enase inhibitor, indomethacin (1 M)  pre-incubated for 20 min
ere tested on the maximal response induced by BK. Curve-ﬁtting
nalyses (GraphPad-Prism software, San Diego, California, USA)
ere used to determine the apparent afﬁnity of agonists in terms
f pD2, which is the negative logarithm of the concentration of
gonist that produces 50% of the maximal effect) and the maximal
ffect (Emax) was calculated in relation to the effect induced by
 M NE, which was considered 100%.ides 42 (2013) 1–7
2.3. Real-time PCR
Animals  of each group were sacriﬁced and their aorta isolated,
dissected and immediately frozen in liquid nitrogen. Total RNA was
isolated using TRIzol® reagent (Invitrogen, Carlsbad, CA, USA). After
puriﬁcation, the presence of intact RNA was  veriﬁed on an ethid-
ium bromide-stained agarose gel. The total RNA was  submitted to
reverse transcription in the presence of 2.5 ng/L of random hex-
anucleotides and 2.5 M of oligo(dT)20, 200 M of dNTP, 10 mM of
MgCl2 and 2 units of SuperScriptTM III First-Strand reverse trans-
criptase (Invitrogen, Carlsbad, CA, USA).
To determine the expression levels of kinin B2 and AT1 recep-
tors, and ACE, real-time PCR was  performed using 5 l of samples
containing 1:10 diluted cDNA. Each reaction was  carried out with
10 L of TaqMan Universal PCR Master Mix  2× (Applied Biosys-
tems, Foster City, CA, USA), 1 L of each pair of speciﬁc primers and
a probe linked with a TAMRA dye and a FAM quencher. The used
primers were for B2R (reverse primer 5′-CACCACGCGGCACAG-
3′, forward primer 5′-ATCACCATCGCCAATAACTTCGA-3′ and
probe 5′-6FAM-CACCTCTCCGAACAGC-TAMRA-3′), for ACE
(reverse primer 5′-CCTGCTGTGGTTCCAGGTACA-3′, forward
primer 5′-AACACGGCTCGTGCAGAAG-3′ and probe, 5′-6FAM-
CCTCCCAGAGTCCAGTCGCGTCA-TAMRA-3′) and for AT1 receptor
(reverse primer 5′-CAGTGTCCACGATGTCAGAAATTTT-3′, for-
ward primer 5′-ACTTTCCTGGATGTGCTGATTCAG-3′ and probe
5′-6FAM-CTGGGCGTCATCCAT-TAMRA-3′) and beta-actin endoge-
nous control (reverse primer 5′-GCCTGGATGGCTACGTACATG-3′,
forward primer 5′-GGCCAACCGTGAAAAGATGAC-3′ and probe
5′-6FAM-CAGATCATGTTTGAGACCTT-TAMRA-3′) and Mili-Q water
(Milipore Corporation) to 20 L.
The real-time PCRs were performed with an ABI PRISM® 7000
sequence detection system (Applied) and cycle conditions were:
50 ◦C for 2 min, 95 ◦C for 10 min, followed by 50 cycles of 95 ◦C for
15 s (melting step), 60 ◦C for 1 min  (anneal/extend step). Increases
in the amount of reporter dye ﬂuorescence during the 50 ampli-
ﬁcation cycles were monitored using Sequence Detector software
(SDS version 1.6, Applied Biosystems). Quantiﬁcation of the target
amount was  performed by measuring the threshold cycle, CT, which
is deﬁned as the fractional cycle number at which the ﬂuorescence
encounters a ﬁxed threshold. A normalized value to evaluate the
mRNA expression was calculated as the difference in the threshold
cycle: the CT values of receptor minus CT of internal standard (-
actin), resulting in CT. Since it is uncommon to use CT parameter
as a relative expression parameter due to this logarithmic char-
acteristic, the 2−CT parameter was  used to express the relative
gene expression data [14]. Final data are expressed as the ratio of
the fold-change in the target gene in the transgenic rat over the
fold-change in the target gene of control rat.
2.4. ACE activity
Thoracic aorta isolated from rat were quickly harvested, rinsed,
blotted, frozed and homogenized in Tris–HCl buffer, pH 7.0, con-
taining 50 mM NaCl and Tween 20, 0.2%. Subsequently, the samples
were centrifuged at 1000 g for 10 min  and the supernatant was
frozen at −20 ◦C. The protein contents of the samples were mea-
sured by the method of Bradford using bovine serum albumin as
standard. The ACE activity was determined using Abz-FRK(Dnp)P-
OH (Abz = ortho-amino benzoic acid; Dnp = ethylenediamine) as
substrates following the methodology previously described [7].
The increase in the ﬂuorescence was continuously measured in a
Hitachi F-7000 ﬂuorimeter set at em = 420 nm and ex = 320 nm
and the assays carried out in 96-well plates (ﬁnal volume in each
well = 0.2 mL). The evaluation of thoracic aorta ACE activity was per-
formed at 37 ◦C in 0.1 M Tris–HCl buffer, pH 7.0, containing 0.05 M
NaCl, 10 M ZnCl2, and inhibitors of the hydrolytic activities that
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Fig. 1. Effect of the overexpression of B1 receptors on the relaxation induced by BK
in rat aorta. Cumulative concentration–response curves for bradykinin (BK) were
determined in thoracic aortic rings isolated from WT and transgenic rat overex-
pressing  the B1 receptor speciﬁcally in the vascular endothelium (TGR(Tie2B1)). The
isometric relaxing responses were calculated in relation to the increased tonus of the
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Fig. 2. Effect of speciﬁc kinin B1 receptor antagonist, R-715, on the relaxant response
induced by bradykinin (BK) in rat thoracic aorta. Effect of R-715 (1 M)  on BK
induced  response in aorta isolated from (A) WT and (B) transgenic rat with endothe-
TGR(Tie2B1) and in non-treated preparations the values were 21 ± 2
(4) for WT  and 50 ± 5 (5) for TGR(Tie2B1). On  the other hand when
1 M HOE-140 was  pre-incubated, BK (100 nM)  induced response
Fig. 3. Effect of speciﬁc kinin B2 receptor antagonist on the relaxant responses
induced  by bradykinin (BK) in rat thoracic aorta. Effect of HOE-140 (1 M)  on theorta induced by 1 M norepinephrine (NE), considered 100%. Data are expressed
s  means ± SD of 5 experiments. *Signiﬁcantly different from control WT animals
P  < 0.05).
e want to suppress (10 M E64, 1 M pepstatin, 1 mM PMSF,
00 M TLCK, and 100 M TPCK). Before starting the reaction by the
ddition of 10 M of Abz-FRK(Dnp)P-OH, the tissues homogenates
ere pre incubated for 5 min  in the assay buffer, at 37 ◦C. To deﬁne
he speciﬁcity for ACE, the assays were also performed in the pres-
nce of the cocktail of inhibitors plus 1 M of the lisinopril. The
lope was converted into nM of substrate hydrolyzed/min. The
easurements were performed in triplicate and the results are
xpressed as means ± SD.
.5.  Drugs and primers
BK,  AngI, AngII, lisinopril, L-NAME, indomethacin and HOE-140
ere purchased from Sigma Chemical Co. (Dorset, U.K). R-715 was
 gift from D. Regoli, Université de Sherbrooke, Quebec, Canada.
Concentrated solutions of peptides and other agents were pre-
ared in water and kept at 20 ◦C until they were used. The
tock solutions were serially diluted with Krebs–Ringer solution.
ligonucleotide primer and ﬂuorogenic probe sets for TaqmanTM
eal-Time PCR were designed for kinin receptors and beta-actin
sing Assays-by-Design Service (Applied Biosystems).
.6. Statistical analysis
Values  are expressed as means ± SD and (n). The Student t-test
as used to determine the statistical differences, with the level of
igniﬁcance set as P < 0.05.
.  Results
.1. Effect of kinin BK on the aortic rings isolated from wild type
nd  transgenic rats overexpressing the B1R
Recordings of the relaxant effect induced by BK were obtained by
umulative increasing concentrations of the agonist into thoracic
ortic preparations isolated from WT  and rat overexpressing the
1R speciﬁcally in the endothelium, TGR(Tie2B1). Non-cumulative
oncentration–response curves induced by BK were not differ-
nt from the cumulative concentration curves. Fig. 1 shows the
oncentration-dependent relaxation to BK in the aortic rings iso-
ated from WT  and TGR(Tie2B1) rats. The maximal responses (%)
ere 21 ± 2 (4) for WT  and 50 ± 5 (5) for TGR(Tie2B1) rats. The pD2
-log EC50, concentration of the agonist that induces 50% of the max-
mal response) values were 8.0 ± 0.3 (4) for WT  and 8.1 ± 0.3 (5) for
GR(Tie2B1).lial  overexpression of kinin B1 receptor (TGR(Tie2B1)). The responses were calculated
in  relation to the effect induced by 1 M norepinephrine (NE), which was considered
100%.  Data are means ± SD of 3 experiments.
3.2. Effect of kinin receptor antagonists on the relaxant responses
induced  by BK in thoracic aorta isolated from TGR(Tie2B1) rats
To evaluate whether the enhanced relaxant responses induced
by BK were partly due to the activation of B1R, the rings of thoracic
aorta isolated from Fig. 2A, WT  and Fig. 2B, rat overexpressing the
B1R speciﬁcally in the vascular endothelium (TGR(Tie2B1)) were
preincubated with 1 M of R-715, speciﬁc inhibitor of B1R. As can
be seen in Fig. 2, concentration–response curves for BK in the rat
thoracic aorta were similar between WT  and TGR(Tie2B1). The pD2
values for BK in the presence of antagonist were 7.8 ± 0.1 (3) for WT
and 7.8 ± 0.2 (3) for TGR(Tie2B1), whereas in preparations with-
out the presence of the antagonist were 8.0 ± 0.3 (4) for WT and
8.1 ± 0.3 (5) for TGR(Tie2B1). The maximal response (%) to BK in
the presence of 1 M R-715 was 21 ± 1 (3) for WT  and 50 ± 3 (3) forrelaxant responses induced by 100 nM BK in rat aorta overexpressing the B1 recep-
tor exclusively in the endothelium (TGR(Tie2B1)) in comparison to the WT rat. The
responses were calculated in relation to the effect induced by 1 M norepinephrine
(NE)  which was  considered 100%. *Signiﬁcantly different (P < 0.05) from control
(without  antagonist) and #different from WT.
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Fig. 4. Effect of L-NAME and indomethacin on bradykinin induced response in rat
aorta. Relaxant responses induced by bradykinin (BK, 1 M)  in the presence or in
the absence of 1 M L-NAME or 1 M indomethacin, pre-incubated for 20 min  in
rings of thoracic aorta isolated from WT  rat and transgenic rat overexpressing the
B1 receptor exclusively in the endothelium (TGR(Tie2B1)). The relaxant responses
were  calculated in relation to the effect induced by 1 M norepinephrine (NE). The
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Fig. 5. Pharmacological determination of ACE activity in thoracic aorta. Cumu-
lative  concentration–relaxant response curves for bradykinin (BK) in thoracic
aorta  isolated from (A), WT and (B), from transgenic rat overexpressing
the  B1 receptor speciﬁcally in the endothelium (TGR(Tie2B1)). Non-cumulative
concentration–contractile response curves for angiotensin I (Ang I) in (C), WT and
in (D), TGR(Tie2B1) rats. The curves were determined in the presence or absence
of  ACE inhibitor lisinopril (1 M),  pre-incubated for 20 min. The isometric relaxant
responses  to BK and contractile responses to AngI are expressed as percentage of
the effect of 1 M norepinephrine (NE), considered 100%. Data are means ± SD of 3
experiments. *Signiﬁcantly different from the control WT animals (P < 0.05).ata shown are the mean ± S.D. of 3 experiments. *Signiﬁcantly different (P < 0.05)
rom the control (without inhibitors) and #different from WT.
as totally inhibited in rat aorta isolated from WT  and TGR(Tie2B1)
s shown in Fig. 3.
.3.  Effect of L-NAME and indomethacin on the
radykinin-induced relaxation
To  verify if the BK-induced relaxation was mediated by NO,
he inhibitor of NO synthase activity was tested. Pre-incubation
ith 1 mM L-NAME for 20 min  completely blocked the maximal
elaxation induced by BK in thoracic rings with endothelium-intact
solated from WT  rat and TGR(Tie2B1). On the other hand, as shown
n Fig. 4, the responses induced by BK in both preparations were
ot blocked by pre-incubation for 20 min  with cyclooxygenase
nhibitor indomethacin (1 M).
.4. Pharmacological determination of ACE activity in thoracic
ings  aorta isolated from transgenic rats overexpressing the B1R
The ﬁnding that the reactivity to BK was enhanced in the trans-
enic kinin B1R knockout mice [20] and that ACE activity can be
nﬂuenced by B2R and B1R [2,27], led us to test the responsiveness
f the thoracic aorta to AngI and to BK in the presence of lisinopril to
valuate a possible change in the ACE activity in TGR(Tie2B1) rats.
The  role of ACE was tested on the relaxing responses to BK
sing lisinopril (1 M)  pre-incubated for 30 min. Under this con-
ition, the curves concentration–responses to BK were obtained in
he thoracic aorta of WT  and TGR(Tie2B1) rats. Fig. 5 shows that
he sigmoidal dose response curves were similar in both prepara-
ions (WT, Fig. 5A and TGR(Tie2B1), Fig. 5B), in comparison to those
btained in the absence of the inhibitor, indicating no signiﬁcant
ifference in the sensitivity of BK to ACE activity in the TGR(Tie2B1)
ats. Moreover, to determine the activity of ACE in TGR(Tie2B1)
ats, on the conversion of AngI to AngII, contractile responses
nduced by AngI pre-incubated for 30 min  with lisinopril were
ested. Concentration–response curves were obtained incubating
on-cumulative concentrations of AngI to avoid desensitization. In
he presence of ACE inhibitor there was similar inhibition of the
esponses throughout all tested concentrations of the agonist in
oth strains of the rats (WT, 5C and TGR(Tie2B1), 5D). The pD2 val-
es expressing the potency and the maximal response (Emax) values
re presented in Table 1.
.5. Determination of ACE activity with Abz-FRK(Dnp)P-OH
ydrolysis
The ACE activity was also determined using a selective ﬂuores-
ence substrate assay for ACE with Abz-FRK(Dnp)P-OH as substrate.These results showed that the hydrolysis of the substrate was not
different between WT  and transgenic rat overexpressing the B1R
(Fig. 6). It was  found that the cleavage of this substrate was com-
pletely abolished by 0.5 M lisinopril.
E.S. Rodrigues et al. / Peptides 42 (2013) 1–7 5
Table  1
Effect of lisinopril on the apparent afﬁnity and maximal responses induced by BK and AngI in rat thoracic aorta.
BK BK + lisinopril Ang I Ang I + lisinopril
pD2 Emax pD2 Emax pD2 Emax pD2 Emax
WT 8.0 ± 0.3(4) 21 ± 2(4) 8.6 ± 0.2(3) 45 ± 3(3)* 7.9 ± 0.3(4) 41 ± 8(4) 7.8 ± 0.2(3) 13 ± 0.8(3)*
TGR(Tie2B1) 8.1 ± 0.3(5) 50 ± 5 (5)# 8.7 ± 0.4(3) 58 ± 5(3)* 8.0 ± 0.3(4) 41 ± 3(4) 7.8 ± 0.3(3) 14 ± 1(3)*
BK induced relaxant responses and contractile responses induced by AngI in the presence or in the absence of ACE inhibitor lisinopril (1 M) in thoracic aorta isolated from
WT  rat and transgenic rat overexpressing the B1 receptor speciﬁcally in the endothelium (TGR(Tie2B1)). The pD2 values (negative logarithm of the agonist concentration (M)
that  induces 50% of the maximal response) were extracted from the concentration–response sigmoid logistic curves. The maximal response (Emax) was  calculated in relation
to  1 M of norepinephrine, which was considered 100%. Data are means ± S.D. and (n) number of experiments.
* Different (P < 0.05) from BK or Ang I (without inhibitor).
# Different from WT.
Fig. 6. Fluorescence assay of ACE activity. ACE activity assay was  performed using
a selective ﬂuorescent substrate for ACE, Abz-FRK(Dnp)P-OH (ortho-aminobenzoic
acid-FRK-(2,4-dinitrophenyl)P-OH) in the thoracic aorta isolated from WT rat and
transgenic rat overexpressing the B1 receptor speciﬁcally in the vascular endothe-
lium  (TGR)Tie2B1)). Data are means ± SD of 3 experiments.
Fig. 7. Relative gene expression of kinin B2 receptor, ACE and angiotensin II type I
receptor. The expression levels of B2 receptor, ACE and angiotensin II type 1 (AT1
receptor) were determined in thoracic aorta isolated from wild-type (WT) rat and
from endothelial overexpressed kinin B1 receptor (TGR(Tie2B1)). The values of mRNA
expression levels were quantiﬁed by real-time PCR. The values of the relative gene
expression were calculated as 2−CT parameter, which is obtained by subtracting
the  CT (threshold cycle) of gene target from the CT of internal standard. Final data
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Fig. 8. Effect of endothelial overexpression of kinin B1 receptors on the contraction
induced  by AngII in rat aorta. Non-cumulative concentration–response curves for
angiotensin II (AngII) were determined in the thoracic aorta isolated from WT rat
and transgenic rat overexpressing the B1 receptor speciﬁcally in the endotheliumre  expressed as the ratio of fold change of cDNA in the transgenic rat (TGR(Tie2B1))
arget gene versus the fold change of cDNA in control. The data are means ± S.D. of
–5 experiments. *Signiﬁcantly different from the control value (P < 0.05).
.6. Expression level of kinin B2 receptors and of ACE
The  expression levels of B2R were determined by real time PCR
elative quantiﬁcation, since the maximum effect induced by BK
n the transgenic TGR(Tie2B1) rats was higher than in the WT  rats.
urthermore, expression level of ACE was evaluated. Fig. 7 shows
he results about the levels of their expression, which was cal-
ulated by fold-up change of the transgenic rat over the control
roup. The expression level of B2R increased about three folds in
he TGR(Tie2B1) rat whereas that of ACE mRNA expression was  not
igniﬁcantly different from the control WT  rats.
.7. Vascular reactivity to angiotensin II and expression level of
T1 receptor in aorta isolated from TGR(Tie2B1) rat
Responsiveness of the thoracic aortic rings to angiotensin II
AngII) induced contractile response was assessed to evaluate(TGR(Tie2B1)). The isometric contractile responses are expressed as percentage of
the effect of 1 M norepinephrine (NE), considered 100%. Data are means ± SD of 5
experiments. *Signiﬁcantly different from the control WT animals (P < 0.05).
any cross-talking between kinin and AT1 receptors under con-
ditions where the expression level of B2R was  shown to be
increased in TGR(Tie2B1) rat. The concentration-responses curves
were obtained using non-cumulative manner for stimulations to
avoid desensitization. The data show that the vascular reactivity
to AngII (Fig. 8) in the aortic rings from TGR(Tie2B1) rats was not
altered when compared to that of WT rat. The maximal response
values (%) were 31 ± 4 (4) for WT and 30 ± 2 (5) for TGR(Tie2B1)
and the pD2 values were 7.8 ± 0.2 (4) for WT and 7.9 ± 0.2 (5) for
TGR(Tie2B1). In addition, the determination of AT1 receptor mRNA
expression revealed that in aorta overexpressing the B1 and B2
receptors, there was  no signiﬁcant difference from the control WT
rats (Fig. 7).
4.  Discussion and conclusion
The  present study showed that the vascular reactivity to BK
as well as the expression level of B2R mRNA were increased in
rats overexpressing the kinin B1R (TGR(Tie2B1)) exclusively in the
endothelium. The relaxation of aortic rings induced by BK was sig-
niﬁcantly greater in this transgenic rat than the control, which
was completely abolished by B2R antagonist HOE-140. The ﬁnd-
ing that the antagonist R-715 could not affect the responses to
BK, indicated that no fragment of the peptide it was mediating the
relaxant responses to BK. Furthermore the complete blockade of the
responses induced by BK by its antagonist HOE-140 showed that
only B2R activation was responsible for the enhanced responses
induced by BK in overexpressing endothelial aorta isolated from
TGR(Tie2B1). It was also found that HOE-140 had no effect on DBK-
induced relaxation, conﬁrming what was reported by [17] that the
increased response induced by DBK in TGR(Tie2B1) was  inhibited
speciﬁcally by the antagonist of B1R. These authors reported that
the responses to DBK were completely blocked by L-NAME in the
isolated aorta from TGR(Tie2B1) rats which is in agreement with
our study wherein a complete inhibition of BK induced effect by
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-NAME was found, indicating that relaxant responses induced by
he kinins in the rat aorta are highly dependent on NO generation.
It  was reported that mice overexpressing B1R in multiple tis-
ues induced hypertensive response to B1R agonist, exacerbated
aw and edema induced by carrageenan and high susceptibil-
ty to endotoxic shock induced by lipopolysaccharide [19]. The
resent study showed that B2R was surprisingly overexpressed
n the endothelium of thoracic aorta from TGR(Tie2B1) rat. This
nding was unexpected since a downregulation should occur as
 counter regulatory mechanism for overexpression of B1R. It has
een reported that the lack of one kinin receptor is compensated
y the up-regulation of the other subtype, as shown in the case of
eletion of B2R [10,12,36] and of B1R [16,28].
In another study [28], lipopolysaccharide treatment caused
nhanced B2R mRNA which was further increased in B1KO mice
ith increased mortality. Although some studies have been
eported about overexpression of B1R [17,19] or B2R [33] assessing
he importance of the overexpressed receptor, the expression of
he other remaining receptor subtype has not been determined.
The  enhanced B2R mRNA expression in TGR(Tie2B1) rat was cor-
elated with the increased responsiveness of rat aorta to its agonist
K. The ﬁnding that the ability of ACE to convert AngI to AngII was
ot reduced neither the ACE mRNA was altered, provided evidence
hat the increase in the BK reactivity was not modulated by ACE
ctivity due to the high expression of the B2R. This conclusion could
ot conﬁrm an effect of ACE/kinin B2R interaction modulating ACE
ctivity as previously described [20,27].
It is noteworthy that was found no evidence for increased activa-
ion of AT1R since the vascular reactivity to AngII was  maintained in
he aorta isolated from (TGR(Tie2B1)) rats. Therefore the hypothesis
hat a spontaneous heterodimerization of AngII and BK receptors
ould trigger the AT1R activation was not conﬁrmed in contrast to
hat previously reported [1].
In conclusion, transgenic rats overexpressing kinin B1R exclu-
ively in the endothelium of TGR(Tie2B1) rats were shown to
verexpress the kinin B2R and to cause increased responsiveness
o BK. It was reported that after lipopolysaccharide treatment,
hese transgenic rats presented a more pronounced hypotensive
esponse and marked bradycardia associated with increased mor-
ality when compared to non-transgenic control rats [17]. It was
lready reported that B1R and B2R were upregulated by endotoxins
nd that B2R mRNA was further increased in B1KO during the acute
hase of endotoxin shock involving increased mortality [28]. There-
ore the mechanism by which B2R mRNA expression is increased
n rats overexpressing kinin B1R needs further investigation. Our
nding supports an important role of B1 and B2 receptors during
he pathogenesis of endotoxic shock. From this study it can be sug-
ested that overexpression and increased activation of kinin B2R
ould be involved in the high mortality during the pathogenesis of
ndotoxic shock, wherein B1R expression is highly induced.
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